Table 2 Demographic and risk characteristics of the 509 women by HIV/HSV serostatus
Definition | HIV+/HSV+ N = 379 (74%) | HIV+/HSV- N = 22 (4%) | HIV-/HSV+ N= 68 (13%) | HIV-/HSV- N = 40 (8%) |
|---|---|---|---|---|
Median age at baseline, years (IQR) | 38 (33-42) | 36 (28-40) | 34 (28-40) | 26(22-30) |
Race n (%) | Â | Â | Â | Â |
   African American | 225 (59%) | 6 (27%) | 45 (66%) | 13 (33%) |
   Hispanic | 79 (21%) | 3 (14%) | 15 (22%) | 7 (18%) |
   White | 55 (15%) | 11 (50%) | 6 (9%) | 18 (45%) |
   Other | 20 (5%) | 2 (9%) | 2 (3%) | 2 (5%) |
Risk exposure | Â | Â | Â | Â |
   Intravenous drug use | 135 (36%) | 6 (27%) | 16 (24%) | 8 (20%) |
   Heterosexual risk | 149 (39%) | 12 (55%) | 11 (16%) | 10 (25%) |
   Transfusion risk | 10 (3%) | 0 (0%) | 1 (1%) | 1 (3%) |
   No identified risk | 85(22%) | 4 (18%) | 40 (59%) | 21 (53%) |
Lifetime # of sex partners | Â | Â | Â | Â |
   0-1 | 16 (4%) | 1 (5%) | 3 (4%) | 1 (3%) |
   2-4 | 51 (13%) | 5 (23%) | 13 (19%) | 6 (15%) |
   5-9 | 81 (21%) | 8 (36%) | 19 (28%) | 10 (25%) |
   10-50 | 122 (32%) | 6 (27%) | 19 (28%) | 21 (53%) |
   > 50 | 108 (28%) | 2 (9%) | 14 (21%) | 2 (5%) |
   missing | 1 (0.3%) | -- | -- | -- |